Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era.
about
Biologic therapies and bone loss in rheumatoid arthritis.Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.
P2860
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Generalized bone loss in early ...... in the biologic treatment era.
@ast
Generalized bone loss in early ...... in the biologic treatment era.
@en
Generalized bone loss in early ...... in the biologic treatment era.
@nl
type
label
Generalized bone loss in early ...... in the biologic treatment era.
@ast
Generalized bone loss in early ...... in the biologic treatment era.
@en
Generalized bone loss in early ...... in the biologic treatment era.
@nl
prefLabel
Generalized bone loss in early ...... in the biologic treatment era.
@ast
Generalized bone loss in early ...... in the biologic treatment era.
@en
Generalized bone loss in early ...... in the biologic treatment era.
@nl
P2093
P2860
P356
P1476
Generalized bone loss in early ...... in the biologic treatment era.
@en
P2093
Anne Prøven
Glenn Haugeberg
Hege Sommerseth
Knut Bjørn Helgetveit
Torhild Garen
Øystein Førre
P2860
P2888
P356
10.1186/1471-2474-15-289
P577
2014-09-02T00:00:00Z
P5875
P6179
1042402581